LIFECORE BIOMEDICAL, INC. Operating Lease Right-of-Use Assets
LIFECORE BIOMEDICAL, INC. (LFCR) had Operating Lease Right-of-Use Assets of $2.23 million as of 2025-02-23, per its 10-Q filed 2025-04-03.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2025-04-03
- 2025-02-23: Operating Lease, Right-of-Use Asset $2.23M.
- 2024-11-24: Operating Lease, Right-of-Use Asset $2.30M.
- 2024-08-25: Operating Lease, Right-of-Use Asset $2.37M.
- 2024-05-26: Operating Lease, Right-of-Use Asset $2.44M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2025-02-23 | $2.23M 10-Q · filed 2025-04-03 | |
| 2024-11-24 | $2.30M 10-Q · filed 2025-01-02 | |
| 2024-08-25 | $2.37M 10-Q · filed 2024-10-04 | |
| 2024-05-26 | $2.44M 10-Q · filed 2025-04-03 | |
| 2024-02-25 | $2.51M 10-Q · filed 2024-08-09 | |
| 2023-11-26 | $4.04M 10-Q · filed 2024-08-09 | |
| 2023-08-27 | $4.16M 10-Q · filed 2024-08-09 | |
| 2023-05-28 | $4.28M 10-K · filed 2024-08-26 | |
| 2023-02-26 | $5.10M 10-K · filed 2024-03-20 | $5.92M 10-Q · filed 2023-06-02 |
| 2022-11-27 | $5.25M 10-K · filed 2024-03-20 | $7.95M 10-Q · filed 2023-03-16 |
| 2022-08-28 | $5.40M 10-K · filed 2024-03-20 | $8.23M 10-Q · filed 2022-10-07 |
| 2022-05-29 | $5.55M 10-K · filed 2024-03-20 | $8.58M 10-K · filed 2022-09-14 |
| 2022-02-27 | $5.70M 10-K · filed 2024-03-20 | $8.80M 10-Q · filed 2022-04-07 |
| 2021-11-28 | $7.49M 10-K · filed 2024-03-20 | $11.98M 10-Q · filed 2022-01-07 |
| 2021-08-29 | $7.70M 10-K · filed 2024-03-20 | $14.30M 10-Q · filed 2021-10-05 |
| 2021-05-30 | $13.54M 10-K · filed 2024-03-20 | $20.83M 10-K · filed 2021-07-29 |
| 2021-02-28 | $15.40M 10-K · filed 2024-03-20 | $23.53M 10-Q · filed 2021-04-08 |
| 2020-11-29 | $12.69M 10-K · filed 2024-03-20 | $21.07M 10-Q · filed 2021-01-07 |
| 2020-08-30 | $13.36M 10-K · filed 2024-03-20 | $22.11M 10-Q · filed 2020-10-07 |
| 2020-05-31 | $25.32M 10-K · filed 2021-07-29 | |
| 2020-02-23 | $25.19M 10-Q · filed 2020-04-03 | |
| 2019-11-24 | $29.78M 10-Q · filed 2020-01-02 | |
| 2019-08-25 | $28.73M 10-Q · filed 2019-10-03 | |
| 2019-05-26 | $0.00 10-K · filed 2020-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |